Alzheimer's Aducanumab Prescribing Information Changes

(MedPage Today) -- Just a month after it gave the new Alzheimer's drug aducanumab (Aduhelm) the green light, the FDA decided to change the label.
The agency approved an updated label narrowing who should receive the drug, stating that aducanumab...